TCMBANKIN058365 |
dicoumarin |
SBI-0051343.P003; DSSTox_RID_76296; Kumoran; AS-19619; Z57170530; KBio2_000645; BSPBio_000890; Dicumarolo; 3,3'-Metilen-bis(4-idrossi-cumarina); Prestwick_90; LS-55258; NC 034; 3,3''''''''-methylenebis(4-hydroxy-coumarin; 4-hydroxy-3-[(4-hydroxy-2-oxo-chromen-3-yl)methyl]chromen-2-one; Spectrum3_000387; 3,3'-Methylenebis[4-hydroxy-2H-1-benzopyran-2-one]; 2H-1-Benzopyran-2-one],3'-methylenebis[4-hydroxy-; AC1L19PT; 3,3'-methanediylbis(4-hydroxy-2H-chromen-2-one); C00796; DSSTox_GSID_21729; Bio-0616; CHEMBL43154; Coumarin, 3,3'-methylenebis[4-hydroxy- (8CI); AB00051966_05; Prestwick0_000785; CHEBI:4513; Antitrombosin; STK801287; AC1Q699Q; UNII-7QID3E7BG7; Cumid; HMS502M18; Dwukumarol; D02TJS; 4-hydroxy-3-[(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]-2H-chromen-2-one; 3,3'-Methylenebis[4-hydroxy-1,2-benzopyrone]; DOBMPNYZJYQDGZ-UHFFFAOYSA-N; Prestwick3_000785; H2893; Spectrum_000165; HMS1570M12; 3,3'-Methylene-bis(4-hydroxycoumarin); bis-hydroxycoumarin; NCGC00016296-04; Dicoumarolum [INN-Latin]; SPBio_000248; MFCD00006857; 5-19-06-00682 (Beilstein Handbook Reference); 3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one); 3,2-benzopyrone]; Pharmakon1600-01500239; NCGC00094650-02; 3,3'-Methylene-bis(4-hydroxycoumarin), 99%; NSC-17860; Dicumol; CHEMBL1466; CTK5C5178; Temparin; GTPL6808; KBio2_003213; VZ31493; Dicumarol [INN-Spanish]; NSC17860; 3,3'-Methylene-bis(4-hydroxycoumarine) [French]; MolPort-000-422-589; Coumarin, 3,3'-methylenebis[4-hydroxy-(8CI); W-203471; Cuma; IDI1_000896; NCGC00016296-02; 3,3'-Methyleen-bis(4-hydroxy-cumarine); 3,3'-Methyleen-bis(4-hydroxy-cumarine) [Dutch]; HY-N0645; 3,3′-Methylenebis(4-hydroxycoumarin); MCULE-8095183287; SCHEMBL33892; HMS2091M10; 3,3'-methylenebis(4-hydroxy-2H-chromen-2-one); Dicumarol, United States Pharmacopeia (USP) Reference Standard; Dicumarolum; Dicumarolo [DCIT]; 3,3''''''''-methylenebis(4-hydroxycoumarin); NCGC00094650-01; 3,3'-Methylene-bis(4-hydroxycoumarine); SPBio_002829; NSC 41834; Di-4-hydroxy-3,3'-methylenedicoumarin; 2H-1-Benzopyran-2-one,3'-methylenebis[4-hydroxy-; Prestwick1_000785; FT-0624734; NCGC00016296-03; NINDS_000896; DivK1c_000896; Dicumarinum; Di-(4-hydroxy-3-coumarinyl)methane; SR-05000001605; 3,3'-Metilen-bis(4-idrossi-cumarina) [Italian]; CCG-34550; 2H-1-Benzopyran-2-one, 3,3'-methylenebis(4-hydroxy-; NSC 221570; SR-05000001605-1; Dufalone; EINECS 200-632-9; Dicoumarol; NCGC00016296-01; Trombosan; HMS1920E20; Dicoumarol (INN); Tox21_110357; 2H-1-Benzopyran-2-one, 3,3'-methylenebis[4-hydroxy-(9CI); 3,3'-Methylene-bis[4-hydroxycoumarin]; Dicumarol [USAN]; NCGC00016296-07; ChemDiv2_003436; 3,3'-methylenebis(2-hydroxy-4h-chromen-4-one); M0216; Apekumarol; Dicoumal; SPECTRUM1500239; AI3-14546; KBioGR_001055; DB00266; 3,3'-Methylen-bis(4-hydroxy-cumarin); 66-76-2; I14-52299; 4,4'-Dihydroxy-3,3'-methylene bis coumarin; BSPBio_002173; Oprea1_150990; SR-05000001605-3; Dicumarol (TN); BBL008904; BPBio1_000980; HMS3714M12; NSC756733; BG01624449; KBioSS_000645; BRD-K82236179-001-05-0; melitoxin; 3,3 -Methylene-bis[4-hydroxycoumarin]; NCGC00016296-05; Coumarin,3'-methylenebis[4-hydroxy-; Dwukumarol [Polish]; Acavyl; Spectrum4_000508; 3,3-Methylene-bis[4-hydroxycoumarin]; AK325302; Bis(4-hydroxycoumarin-3-yl)methane; D03798; Dicumarol (USAN); dicoumarol; Dikumarol; 2H-1-Benzopyran-2-one, 3,3'-methylenebis(4-hydroxy)-; KBio3_001393; SR-05000001605-4; DSSTox_CID_1729; Baracoumin; 2-hydroxy-3-[(2-hydroxy-4-oxochromen-3-yl)methyl]chromen-4-one; CAS-66-76-2; Dicumarol [USAN:USP]; CBDivE_003005; BDBM35525; Tox21_110357_1; NSC-756733; 3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone); Dicuman; Acadyl; 4-hydroxy-3-((4-hydroxy-2-oxo-2H-chromen-3-yl)methyl)-2H-chromen-2-one; SCHEMBL33891; Dicumaol R; 4-hydroxy-3-[(4-hydroxy-2-oxochromen-3-yl)methyl]chromen-2-one; WLN: T66 BOVJ EQ D1- DT66 BOVJ EQ; NSC 17860; Dicoumarol [INN]; KBio1_000896; Dicoumerol; 3,3'-Methylen-bis(4-hydroxy-cumarin) [German]; NSC221570; Dicumarine; BRN 0335444; Spectrum5_000871; Bis-3,3'-(4-hydroxycoumarinyl)methane; dicumarol; Coumarin, 3,3'-methylenebis(4-hydroxy-; CCRIS 3713; 7QID3E7BG7; KBio2_005781; Y1603; 2H-1-Benzopyran-2-one), 3,3'-methylenebis(4-hydroxy-; CS-7962; Dicoumarolum; HSDB 3223; Prestwick2_000785; 3,3''''''''-methylenebis[4-hydroxycoumarin; DTXSID8021729; s4299; 3,3'-Methylenebis(4-hydroxycoumarin); ZINC3869855; 2H-1-Benzopyran-2-one,3,3'-methylenebis[4-hydroxy-; C19H12O6; 2H-1-Benzopyran-2-one, 3,3'-methylenebis[4-hydroxy- (9CI); 3,3'-Methylenebis[4-hydroxycoumarin]; Anathrombase; NSC41834; 3,3′ HMS3652P10; BG00665451; symmetric dicoumarol analogue, 1; AKOS000520650; Bis-3,3'-(4-oxycoumarinyl)ethylacetate; HMS1378M04; HMS2097M12; 2H-1-Benzopyran-2-one, 3,3'-methylenebis[4-hydroxy-; uncoupler of oxidative respiration; Spectrum2_000144; Bishydroxycoumarin;dicoumarol |
C19H12O6 |
336.3 g/mol |
C1=CC=C2C(=C1)C(=C(C(=O)O2)CC3=C(C4=CC=CC=C4OC3=O)O)O |